Janzic, U.; Bidovec-Stojkovic, U.; Korosec, P.; Mohorcic, K.; Mrak, L.; Caks, M.; Ravnik, M.; Skof, E.; Rijavec, M.
A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers. Vaccines 2023, 11, 1017.
https://doi.org/10.3390/vaccines11061017
AMA Style
Janzic U, Bidovec-Stojkovic U, Korosec P, Mohorcic K, Mrak L, Caks M, Ravnik M, Skof E, Rijavec M.
A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers. Vaccines. 2023; 11(6):1017.
https://doi.org/10.3390/vaccines11061017
Chicago/Turabian Style
Janzic, Urska, Urska Bidovec-Stojkovic, Peter Korosec, Katja Mohorcic, Loredana Mrak, Marina Caks, Maja Ravnik, Erik Skof, and Matija Rijavec.
2023. "A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers" Vaccines 11, no. 6: 1017.
https://doi.org/10.3390/vaccines11061017
APA Style
Janzic, U., Bidovec-Stojkovic, U., Korosec, P., Mohorcic, K., Mrak, L., Caks, M., Ravnik, M., Skof, E., & Rijavec, M.
(2023). A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers. Vaccines, 11(6), 1017.
https://doi.org/10.3390/vaccines11061017
